HOYA CORPORATION (HOCPY)
OTHER OTC:HOCPY
Want to see HOCPY full AI Analyst Report?
Top Page
HOYA
(OTC:HOCPY)
Select Model
Select Model
Rating:71Outperform
Price Target:
$196.00
▲(28.05% Upside)
Action:Reiterated
Date:05/02/26
The score is driven primarily by strong financial performance (high profitability, strong cash generation, and very low leverage). Offsetting this, technicals are mixed with the stock below key short-term averages, and valuation is less attractive due to a high P/E and low dividend yield.
Positive Factors
Balance Sheet Strength
HOYA's minimal leverage and steadily growing equity give the company durable financial flexibility to invest in R&D, M&A, and capital equipment. Low debt reduces refinancing and interest-rate vulnerability, supporting long-term operational continuity and strategic optionality across cycles.
Negative Factors
Year-to-Year Variability
HOYA shows meaningful volatility across annual results; uneven growth and profit swings suggest sensitivity to product mix, timing of orders, and cost dynamics. This variability complicates forecasting and can strain planning for capex or resource allocation over multi-quarter horizons.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance Sheet Strength
HOYA's minimal leverage and steadily growing equity give the company durable financial flexibility to invest in R&D, M&A, and capital equipment. Low debt reduces refinancing and interest-rate vulnerability, supporting long-term operational continuity and strategic optionality across cycles.
Read all positive factors
HOYA (HOCPY) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$55.08B
Dividend Yield0.84%
Average Volume (3M)507.00
Price to Earnings (P/E)35.0
Beta (1Y)0.68
Revenue Growth10.61%
EPS Growth29.06%
CountryUS
Employees35,702
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)756.23
Shares Outstanding334,838,000
10 Day Avg. Volume0
30 Day Avg. Volume507
Financial Highlights & Ratios
PEG Ratio0.97
Price to Book (P/B)9.09
Price to Sales (P/S)9.27
P/FCF Ratio39.61
Enterprise Value/Market Cap154.82
Enterprise Value/Revenue8.87
Enterprise Value/Gross Profit11.04
Enterprise Value/Ebitda19.99
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)5.07
Revenue Forecast (FY)$6.50B
HOYA Business Overview & Revenue Model
Company Description
HOYA Corporation is a Japanese multinational company that specializes in the manufacturing of optical products, including lenses for eyeglasses and cameras, as well as healthcare products and semiconductor-related materials. Established in 1941, H...
How the Company Makes Money
HOYA makes money by manufacturing and selling products in two broad areas: (1) Healthcare/optics and (2) Information technology/industrial components.
1) Vision care (eyeglass lenses and related optical products)
- Revenue model: Primarily produc...
HOYA Financial Statement Overview
Summary
Income Statement
88
Very Positive
Balance Sheet
92
Very Positive
Cash Flow
86
Very Positive
| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.00T | 885.82B | 762.61B | 734.10B | 670.33B |
| Gross Profit | 793.79B | 766.25B | 421.69B | 631.86B | 567.28B |
| EBITDA | 359.07B | 310.00B | 285.70B | 259.78B | 243.96B |
| Net Income | 268.35B | 202.10B | 181.38B | 168.64B | 164.51B |
Balance Sheet | |||||
| Total Assets | 1.31T | 1.23T | 1.20T | 1.03T | 992.84B |
| Cash, Cash Equivalents and Short-Term Investments | 576.58B | 538.53B | 525.16B | 426.27B | 426.63B |
| Total Debt | 42.42B | 37.28B | 29.24B | 24.58B | 21.60B |
| Total Liabilities | 267.05B | 262.65B | 241.36B | 213.72B | 203.78B |
| Stockholders Equity | 1.02T | 974.02B | 967.76B | 818.32B | 803.85B |
Cash Flow | |||||
| Free Cash Flow | 235.25B | 187.19B | 181.73B | 168.36B | 161.18B |
| Operating Cash Flow | 295.24B | 235.11B | 222.80B | 201.83B | 190.06B |
| Investing Cash Flow | -8.04B | -33.19B | -35.81B | -47.50B | -29.30B |
| Financing Cash Flow | -277.01B | -190.35B | -110.89B | -194.59B | -106.72B |
HOYA Technical Analysis
Negative
153.06
Price Trends
175.55
Negative
174.35
Negative
161.22
Positive
Market Momentum
-2.97
Positive
40.85
Neutral
46.58
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HOCPY, the sentiment is Negative. The current price of 153.06 is below the 20-day moving average (MA) of 169.78, below the 50-day MA of 175.55, and below the 200-day MA of 161.22, indicating a neutral trend. The MACD of -2.97 indicates Positive momentum. The RSI at 40.85 is Neutral, neither overbought nor oversold. The STOCH value of 46.58 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HOCPY.
HOYA Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $22.42B | 41.72 | 17.87% | 0.32% | 11.24% | 17.11% | |
75 Outperform | $148.33B | 50.28 | 17.01% | ― | 21.43% | 20.38% | |
73 Outperform | $28.19B | 18.90 | 24.41% | 0.92% | 10.28% | 16.40% | |
71 Outperform | $55.08B | 35.04 | 25.12% | 0.84% | 10.61% | 29.06% | |
64 Neutral | $41.21B | 37.28 | 4.54% | 2.13% | 2.39% | -24.85% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
HOCPY
HOYA
164.35
50.68
44.58%
BDX
Becton Dickinson
151.16
17.98
13.50%
ISRG
Intuitive Surgical
422.06
-135.02
-24.24%
RMD
Resmed
196.04
-53.71
-21.51%
WST
West Pharmaceutical Services
314.50
90.55
40.43%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.